Your browser is no longer supported. Please, upgrade your browser.
Settings
LLY Eli Lilly and Company daily Stock Chart
LLY [NYSE]
Eli Lilly and Company
IndexS&P 500 P/E46.83 EPS (ttm)2.27 Insider Own11.20% Shs Outstand1.09B Perf Week-6.99%
Market Cap115.77B Forward P/E18.28 EPS next Y5.83 Insider Trans-3.37% Shs Float1.06B Perf Month-5.08%
Income2.36B PEG3.68 EPS next Q1.36 Inst Own80.00% Short Float0.81% Perf Quarter-0.36%
Sales24.28B P/S4.77 EPS this Y-37.00% Inst Trans-0.65% Short Ratio1.86 Perf Half Y22.67%
Book/sh12.82 P/B8.31 EPS next Y4.39% ROA1.00% Target Price115.00 Perf Year23.06%
Cash/sh8.31 P/C12.81 EPS next 5Y12.73% ROE3.50% 52W Range73.69 - 119.84 Perf YTD26.10%
Dividend2.25 P/FCF50.96 EPS past 5Y-15.00% ROI6.60% 52W High-11.13% Beta0.33
Dividend %2.11% Quick Ratio1.50 Sales past 5Y0.20% Gross Margin73.40% 52W Low44.52% ATR2.82
Employees40655 Current Ratio1.90 Sales Q/Q7.10% Oper. Margin12.30% RSI (14)33.01 Volatility2.51% 2.32%
OptionableYes Debt/Eq0.97 EPS Q/Q112.90% Profit Margin1.90% Rel Volume1.41 Prev Close108.36
ShortableYes LT Debt/Eq0.89 EarningsNov 06 BMO Payout492.40% Avg Volume4.61M Price106.50
Recom2.40 SMA20-6.98% SMA50-5.00% SMA20011.65% Volume6,475,758 Change-1.72%
Nov-26-18Downgrade Citigroup Buy → Neutral
Oct-31-18Upgrade Credit Suisse Underperform → Neutral
Oct-09-18Initiated Guggenheim Buy
Oct-01-18Reiterated SunTrust Buy $105 → $123
Sep-26-18Resumed JP Morgan Overweight $117
Jul-25-18Downgrade Berenberg Buy → Hold
Jun-08-18Initiated Cantor Fitzgerald Overweight $100
Apr-13-18Upgrade BMO Capital Markets Underperform → Market Perform $74 → $79
Jan-22-18Downgrade Credit Suisse Neutral → Underperform
Jan-16-18Downgrade Goldman Buy → Neutral
Jan-05-18Upgrade Argus Hold → Buy
Oct-10-17Downgrade Credit Suisse Outperform → Neutral
Jul-26-17Downgrade Leerink Partners Outperform → Mkt Perform
Apr-27-17Downgrade Argus Buy → Hold
Apr-17-17Downgrade Morgan Stanley Overweight → Equal-Weight
Apr-07-17Reiterated Barclays Overweight $85 → $90
Mar-20-17Reiterated UBS Neutral $70 → $85
Dec-16-16Upgrade Morgan Stanley Equal-Weight → Overweight
Sep-27-16Upgrade Goldman Neutral → Buy
Sep-08-16Upgrade JP Morgan Neutral → Overweight
Dec-18-18 04:15PM  Lilly and Aduro Biotech Announce Research Collaboration and License Agreement to Develop Novel Immunotherapies PR Newswire
10:12AM  A Look At The Intrinsic Value Of Eli Lilly and Company (NYSE:LLY) Simply Wall St.
10:00AM  Lilly's Taltz Outshines Humira in Psoriatic Arthritis Study Zacks
09:50AM  Teva Reports Positive Top-Line Data for Migraine Candidate Zacks
06:45AM  Lilly announces publication of analyses showing benefit of the addition of Verzenio® (abemaciclib) in multiple subgroups of patients with advanced breast cancer identified as having a more concerning prognosis PR Newswire
Dec-17-18 03:22PM  Merck to Acquire Europe's Antelliq Group for $2.4 Billion Zacks
02:53PM  Incyte (INCY) Collaborates with Innovent for 3 Candidates Zacks
12:25PM  7 Major Pharmaceutical Stocks to Quarantine Now InvestorPlace
09:48AM  Lilly (LLY) to Acquire Pain Candidate From Private Biotech Zacks
09:22AM  J&J Dips 10% as Reuters Says Company Knew of Asbestos in Talc Zacks
08:18AM  Better Buy: Eli Lilly and Company vs. Merck & Co. Motley Fool
08:12AM  Dow Jones Futures: The Worst Part About This Stock Market Rally Investor's Business Daily
06:48AM  Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trial Reuters
06:45AM  Lilly Announces Positive Top-Line Results for Taltz® (ixekizumab) vs. Humira® (adalimumab) in a Head-to-Head (SPIRIT-H2H) Superiority Study in Patients with Active Psoriatic Arthritis PR Newswire
Dec-14-18 03:30PM  Lilly to Acquire Pre-Clinical Pain Program from Hydra Biosciences PR Newswire
12:32PM  Mylan (MYL) Gets Favorable Ruling Against Sanofi's Lantus Zacks
09:30AM  Is Eli Lilly and (LLY) Outperforming Other Medical Stocks This Year? Zacks
08:41AM  Merck bolsters animal health unit with $2.4 bln Antelliq purchase Reuters
08:23AM  5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019 Zacks
08:19AM  Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus Zacks
06:45AM  Lilly and Evidation Health Expand Collaboration to Analyze Data from Smartphones and Connected Sensors PR Newswire
Dec-13-18 10:28AM  Stocks - Ciena Jumps in Premarket, Apple Gains, Tailored Brands Crashes Investing.com
09:27AM  Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now? Zacks
09:00AM  Lilly Inks Deal With AC Immune for Potential Alzheimer's Drug Zacks
06:45AM  FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE) PR Newswire
06:30AM  Boehringer Ingelheim and Lilly Partner with Duke Clinical Research Institute to Advance Multidisciplinary Care for People with Type 2 Diabetes and Cardiovascular Disease PR Newswire
Dec-12-18 07:51AM  Lilly partners with AC Immune for Alzheimer's treatment Reuters
06:51AM  Lilly partners with AC Immune for Alzheimer's treatment Reuters
06:30AM  AC Immune and Lilly Announce License and Collaboration Agreement Business Wire
06:10AM  Lilly partners with AC Immune for Alzheimer's treatment Reuters
06:00AM  Lilly and AC Immune Announce License and Collaboration Agreement PR Newswire
Dec-11-18 09:51AM  Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800 Zacks
Dec-10-18 10:10AM  The Zacks Analyst Blog Highlights: Eli Lilly, Anthem, BlackRock, CME Group and Southern Company Zacks
Dec-09-18 11:24AM  Why Costco Leads 5 Top Stocks That Could Lead When Market Conditions Improve Investor's Business Daily
09:43AM  Eli Lilly and Company (LLY): Are Hedge Funds Right About This Stock? Insider Monkey
Dec-07-18 03:14PM  Mallinckrodt (MNK) to Separate Generics & Branded Businesses Zacks
11:56AM  7 Stocks to Buy to Survive a Bear Market InvestorPlace
Dec-06-18 09:30AM  Why Is Lilly (LLY) Up 6.2% Since Last Earnings Report? Zacks
06:59AM  Four stocks have avoided the market crush to hit new highs CNBC
Dec-05-18 10:00AM  Eli Lilly (LLY) is a Great Momentum Stock: Should You Buy? Zacks
09:03AM  The Zacks Analyst Blog Highlights: Verizon, Eli Lilly, Accenture, VMware and Schwab Zacks
07:00AM  Today's Research Reports on Trending Tickers: Eli Lilly and Company and AstraZeneca ACCESSWIRE
Dec-04-18 05:25PM  Incyte (INCY) Announces Positive Data on Jakafi for GVHD Zacks
07:00AM  Bayer Is Just the Latest Pharma Giant to Get Back to Basics Barrons.com
06:00AM  3 Big Pharma Stocks Hitting 52-Week Highs -- Are They Buys? Motley Fool
Dec-03-18 10:15AM  NCCN Oncology Research Program Awarded $2 Million from Lilly to Study Mechanisms of Resistance to CDK4 & 6 Inhibitors in Breast Cancer Treatment PR Newswire
07:40AM  Investor Expectations to Drive Momentum within Virtu Financial, Fate Therapeutics, Tandem Diabetes Care, Eli Lilly, Griffon, and Coherus BioSciences Discovering Underlying Factors of Influence GlobeNewswire
Nov-30-18 05:50PM  Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know Zacks
03:45PM  Insiders Roundup: Walmart, Eli Lilly GuruFocus.com
10:34AM  3 Tips for Trading the Fed's More Dovish Stance TheStreet.com
09:15AM  Lilly (LLY) Hits Fresh High: Is There Still Room to Run? Zacks
Nov-29-18 04:21PM  Merck (MRK) Receives Approval for 2 HIV Medicines in EU Zacks
09:17AM  Alkermes touts 'positive' schizophrenia drug data, but investors not impressed American City Business Journals
08:10AM  4 Big Pharma Stocks to Add to Your Portfolio in December Zacks
06:45AM  Lilly to Present Clinical Data for Verzenio® (abemaciclib) and Real-World Evidence across HR+, HER2- Metastatic Breast Cancer at 2018 SABCS PR Newswire
Nov-28-18 09:30AM  Is Eli Lilly and (LLY) Stock Outpacing Its Medical Peers This Year? Zacks
Nov-27-18 05:47PM  Zafgen (ZFGN) Plunges as FDA Puts Hold on Diabetes Drug Trial Zacks
06:30AM  Lilly to Announce 2019 Financial Guidance, Highlight Late-Stage Pipeline Opportunities and Discuss Commercial Performance at Upcoming Investment Community Meeting PR Newswire
02:00AM  American College of Cardiology recommends empagliflozin as preferred SGLT2 inhibitor for adults with type 2 diabetes and established cardiovascular disease in new Expert Consensus Decision Pathway PR Newswire
Nov-26-18 02:34PM  Jardiance® Recommended as Preferred SGLT2 Inhibitor for Adults with Type 2 Diabetes and Established Cardiovascular Disease in American College of Cardiology Expert Consensus Decision Pathway PR Newswire
09:43AM  4 Reasons Why Lilly is Up More Than 30% This Year So Far Zacks
Nov-21-18 04:19PM  This Highly Rated Pharma Giant Is More Than Just A Diabetes Player Investor's Business Daily
02:00PM  Eli Lilly's Stock May Drop 7% Short-Term Investopedia
08:04AM  Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Hot ETF Right Now? Zacks
Nov-20-18 04:24PM  Corcept Initiates Phase III Study for Cushing's Syndrome Zacks
Nov-19-18 05:50PM  Eli Lilly (LLY) Gains As Market Dips: What You Should Know Zacks
03:23PM  3 Steady Healthcare Stocks to Hold During a Downturn InvestorPlace
Nov-16-18 01:45PM  Top Stocks: IBD Screens Uncover Emerging Leaders Before Big Moves Investor's Business Daily
08:56AM  Eli Lilly considers sale of off-patent drug assets in China - Bloomberg Reuters
08:35AM  Pharma Stock Roundup: FDA Updates on MRK, AZN's Cancer Drugs, Bayer's Q3 Earnings Zacks
07:59AM  Seattle Genetics' Adcetris Gets Breakthrough Therapy Status Zacks
07:53AM  Eli Lilly considers sale of off-patent drug assets in China - Bloomberg Reuters
02:05AM  Eli Lilly Considers Sale of China Assets to Raise Cash Bloomberg
Nov-15-18 04:09PM  Mallinckrodt Gets FDA Committee Vote for Abuse-Deterrent Drug Zacks
10:15AM  Lilly Offers Updates on Progress of Headache Disorder Drugs Zacks
09:16AM  Exelixis, Ipsen Get EU Nod for Label Expansion of Cabometyx Zacks
Nov-14-18 04:06PM  Migraine-Focused Biotech Has A Headache On Quarterly Losses Investor's Business Daily
03:34PM  AbbVie's HCV Drug Mavyret Succeeds in Label Expansion Study Zacks
10:15AM  Merck Starts Rolling BLA Submission for Ebola Vaccine V920 Zacks
08:02AM  Shire's Filing Accepted by FDA for Gattex's Label Expansion Zacks
07:52AM  Eli Lilly announces progress on new headache medications MarketWatch
06:45AM  Lilly Submits New Drug Application to the FDA for Lasmiditan for Acute Treatment of Migraine, Receives Breakthrough Therapy Designation for Emgality (galcanezumab-gnlm) for Prevention of Episodic Cluster Headache PR Newswire
Nov-13-18 06:37PM  More and More Hedge Funds Are Selling Eli Lilly and Company (LLY) Insider Monkey
01:17PM  Bayer (BAYRY) Beats on Q3 Earnings, Revenue Estimates Zacks
07:00AM  Walmart, Home Depot adopt health insurer tactic in drug copay battle Reuters
Nov-12-18 05:50PM  Eli Lilly (LLY) Gains As Market Dips: What You Should Know Zacks
04:15PM  IBD Stock Of The Day Nears Buy Point As It Outperforms Big Pharma Rivals Investor's Business Daily
03:46PM  5 Stocks to Sell After the Midterm Election InvestorPlace
Nov-09-18 03:17PM  Catalyst (CPRX) Reports Q3 Loss as Expected & Pipeline Update Zacks
02:23PM  Keryx's (KERX) Loss Narrower Than Expected in Q3, Sales Lag Zacks
07:31AM  Pharma Stock Roundup: LLY, AZN Report Q3 Earnings, PFE Gets FDA Nod for Cancer Drug Zacks
Nov-08-18 04:30PM  Lilly to Participate in Credit Suisse 27th Annual Healthcare Conference PR Newswire
02:53PM  Novo Nordisk Continues Its Balancing Act Motley Fool
11:13AM  Horizon Pharma (HZNP) Q3 Earnings & Sales Beat, Shares Rise Zacks
10:43AM  Nektar (NKTR) Q3 Earnings & Sales Beat Estimates, Shares Up Zacks
Nov-07-18 04:53PM  Better Buy: Eli Lilly and Company vs. AbbVie Inc. Motley Fool
04:08PM  Mallinckrodt (MNK) Beats on Q3 Earnings Estimates, Ups View Zacks
12:22PM  Drug Stocks Climb as Investors Digest Midterm Election Results TheStreet.com
07:55AM  Edited Transcript of LLY earnings conference call or presentation 6-Nov-18 2:00pm GMT Thomson Reuters StreetEvents
Nov-06-18 06:21PM  Stocks - Dow Rallies as Midterm Mania Grips Wall Street Investing.com
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide. The company operates through two segments, Human Pharmaceutical Products and Animal Health Products. It offers endocrinology products for the treatment of diabetes; osteoporosis in postmenopausal women and men; and human growth hormone deficiency and pediatric growth conditions. The company also provides neuroscience products for the treatment of depressive disorder, diabetic peripheral neuropathic pain, anxiety disorder, fibromyalgia, and chronic musculoskeletal pain; schizophrenia; attention-deficit hyperactivity disorder; obsessive-compulsive disorder, bulimia nervosa, and panic disorder; and positron emission tomography imaging of beta-amyloid neurotic plaques in adult brains, as well as immunology products to treat Alzheimer's disease. In addition, it offers oncology products to treat non-small cell lung, colorectal, head and neck, pancreatic, metastatic breast, ovarian, bladder, and metastatic gastric cancers, as well as malignant pleural mesothelioma; and cardiovascular products to treat erectile dysfunction and benign prostatic hyperplasia; and migraine. Further, the company provides animal health products, such as cattle feed additives; protein supplements for cows; leanness and performance enhancers for swine and cattle; antibiotics to treat respiratory and other diseases in cattle, swine, and poultry; anticoccidial agents for poultry use; and chewable tablets that kill fleas and prevent heartworm diseases. Additionally, it offers vaccines to prevent bordetella, Lyme disease, rabies, and parvovirus. The company has collaboration agreements with Daiichi Sankyo Co., Ltd.; Incyte Corporation; Pfizer Inc.; AstraZeneca; Nektar Therapeutics; NextCure, Inc.; and Dicerna Pharmaceuticals, Inc., as well as has strategic collaboration with Sigilon Therapeutics. Eli Lilly and Company was founded in 1876 and is headquartered in Indianapolis, Indiana.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'Neill MylesSVP & Pres., Mfg. OperationsDec 10Sale112.9225,0002,822,95950,954Dec 12 03:15 PM
LILLY ENDOWMENT INC10% OwnerDec 04Sale119.0015,5001,844,536118,015,304Dec 06 03:43 PM
White Anne E.SVP & Pres-Lilly OncologyDec 02Option Exercise0.007,500017,103Dec 04 03:14 PM
LILLY ENDOWMENT INC10% OwnerNov 29Sale117.42185,00021,722,429118,030,804Nov 30 11:52 AM
LILLY ENDOWMENT INC10% OwnerNov 28Sale115.57190,00021,957,939118,215,804Nov 29 10:55 AM
LILLY ENDOWMENT INC10% OwnerNov 19Sale115.31195,00022,485,572118,405,804Nov 20 02:40 PM
LILLY ENDOWMENT INC10% OwnerNov 16Sale113.74200,00022,747,000118,600,804Nov 19 01:53 PM
LILLY ENDOWMENT INC10% OwnerNov 13Sale113.412,460278,979118,800,804Nov 14 10:44 AM
LILLY ENDOWMENT INC10% OwnerNov 12Sale113.48202,54022,984,877118,803,264Nov 13 10:51 AM
LILLY ELI & CO10% OwnerNov 06Sale14.00700,0009,800,0003,148,647Nov 08 11:34 AM
Norton JohnaSenior VP, Global QualityNov 03Option Exercise0.003,133019,225Nov 06 01:25 PM
LILLY ENDOWMENT INC10% OwnerOct 17Sale113.25174,69619,783,623119,005,804Oct 18 02:26 PM
LILLY ENDOWMENT INC10% OwnerOct 09Sale115.9110,6721,237,013119,180,500Oct 10 01:17 PM
LILLY ENDOWMENT INC10% OwnerOct 08Sale115.9114,6321,696,039119,191,172Oct 09 01:14 PM
LILLY ENDOWMENT INC10% OwnerOct 04Sale112.67116,03813,073,950119,205,804Oct 05 02:47 PM
Zulueta Alfonso GSVP & President, Lilly Int'lOct 04Sale114.647,000802,48045,224Oct 05 02:08 PM
LILLY ENDOWMENT INC10% OwnerOct 03Sale109.0178,9628,607,253119,321,842Oct 04 02:29 PM
LILLY ENDOWMENT INC10% OwnerSep 28Sale107.31107,55311,541,082119,400,804Oct 01 11:53 AM
LILLY ENDOWMENT INC10% OwnerSep 27Sale107.0092,4479,891,644119,508,357Sep 28 10:36 AM
LILLY ENDOWMENT INC10% OwnerSep 26Sale106.63134,41014,332,373119,600,804Sep 27 12:26 PM
LILLY ENDOWMENT INC10% OwnerSep 25Sale106.4155,5905,915,165119,735,214Sep 26 01:49 PM
LILLY ELI & CO10% OwnerSep 24Sale16.362,02733,1623,848,647Sep 26 02:50 PM
LILLY ELI & CO10% OwnerSep 18Sale14.566,870100,0273,850,674Sep 20 04:50 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 18Sale107.003,000321,00052,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 17Sale14.586,865100,0923,857,544Sep 18 07:30 PM
Zulueta Alfonso GSVP & President, Lilly Int'lSep 17Sale105.613,000316,83055,224Sep 19 05:47 PM
LILLY ELI & CO10% OwnerSep 14Sale14.589,009131,3513,864,409Sep 18 07:30 PM
LILLY ELI & CO10% OwnerSep 13Sale14.3220,900299,2883,873,418Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 12Sale14.8310,059149,1753,894,318Sep 14 03:34 PM
LILLY ELI & CO10% OwnerSep 11Sale14.8711,277167,6893,904,377Sep 12 04:39 PM
LILLY ELI & CO10% OwnerSep 10Sale14.444,50064,9803,915,654Sep 12 04:39 PM
LILLY ENDOWMENT INC10% OwnerSep 07Sale106.76180,00019,217,055119,790,804Sep 10 12:44 PM
Zakrowski Donald AChief Accounting OfficerSep 04Sale105.5760063,3423,530Sep 04 04:50 PM
LILLY ELI & CO10% OwnerAug 31Sale14.267009,9823,920,154Sep 04 03:38 PM
LILLY ELI & CO10% OwnerAug 30Sale14.353,44049,3643,920,854Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 30Sale105.42190,00020,030,370119,970,804Aug 31 09:07 AM
LILLY ELI & CO10% OwnerAug 29Sale14.262,31232,9693,924,294Aug 31 12:40 PM
LILLY ENDOWMENT INC10% OwnerAug 20Sale105.89195,00020,647,575120,160,804Aug 21 02:12 PM
LILLY ENDOWMENT INC10% OwnerAug 16Sale104.50200,00020,899,800120,355,804Aug 17 03:08 PM
LILLY ENDOWMENT INC10% OwnerAug 15Sale103.23151,79315,669,440120,555,804Aug 16 02:52 PM
LILLY ELI & CO10% OwnerAug 14Sale14.283,00042,8403,926,606Aug 16 03:34 PM
LILLY ELI & CO10% OwnerAug 13Sale14.334,53164,9293,929,606Aug 14 05:04 PM
LILLY ELI & CO10% OwnerAug 10Sale14.281,89827,1033,934,137Aug 14 05:04 PM
LILLY ENDOWMENT INC10% OwnerAug 10Sale103.063,587369,676120,707,597Aug 13 03:41 PM
LILLY ENDOWMENT INC10% OwnerAug 07Sale103.2224,6202,541,326120,711,184Aug 08 01:28 PM
LILLY ENDOWMENT INC10% OwnerAug 06Sale102.15195,00019,918,860120,735,804Aug 07 11:46 AM
LILLY ELI & CO10% OwnerAug 03Sale13.551,65022,3583,936,035Aug 07 03:16 PM
LILLY ELI & CO10% OwnerAug 02Sale13.3119,400258,2143,937,685Aug 03 03:53 PM
LILLY ENDOWMENT INC10% OwnerAug 02Sale99.58190,00018,919,939120,930,804Aug 03 02:31 PM
LILLY ENDOWMENT INC10% OwnerJul 31Sale98.74205,00020,240,873121,120,804Aug 01 01:12 PM
TAI JACKSON PDirectorJul 26Buy95.222,168206,43753,228Jul 27 10:46 AM
LILLY ENDOWMENT INC10% OwnerJul 25Sale94.73190,00017,999,259121,325,804Jul 26 02:17 PM
LILLY ENDOWMENT INC10% OwnerJul 24Sale92.03185,00017,025,985121,515,804Jul 25 11:47 AM
LILLY ENDOWMENT INC10% OwnerJul 06Sale87.44180,00015,738,300121,700,804Jul 09 10:45 AM
Pusey Leigh AnnSVP, Corp. Affairs & Comm.Jul 05Option Exercise0.002,39402,394Jul 09 11:58 AM
LILLY ENDOWMENT INC10% OwnerJul 05Sale86.62170,00014,725,740121,880,804Jul 06 11:13 AM
LILLY ENDOWMENT INC10% OwnerJun 15Sale86.65180,00015,597,720122,050,804Jun 18 12:39 PM
Skovronsky DanielSVP, CSO, and Pres. LRLJun 14Buy86.2210,000862,20055,199Jun 14 04:08 PM
LILLY ENDOWMENT INC10% OwnerJun 14Sale86.31107,6989,295,414122,230,804Jun 15 11:00 AM
LILLY ENDOWMENT INC10% OwnerJun 13Sale86.2711,104957,953122,338,502Jun 14 11:58 AM
LILLY ENDOWMENT INC10% OwnerJun 11Sale86.3851,1984,422,637122,349,606Jun 12 02:46 PM
LILLY ENDOWMENT INC10% OwnerJun 04Sale85.13135,47811,532,565122,400,804Jun 05 11:20 AM
LILLY ENDOWMENT INC10% OwnerJun 01Sale85.3139,5223,371,661122,536,282Jun 04 02:25 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 31Sale85.0025,0002,125,000124,534Jun 01 04:22 PM
LILLY ENDOWMENT INC10% OwnerMay 30Sale83.85180,00015,092,640122,575,804May 31 01:18 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 29Sale82.108,426691,7750May 31 01:05 PM
LILLY ENDOWMENT INC10% OwnerMay 11Sale81.97140,00011,475,940122,755,804May 14 02:29 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 03Sale78.509,027708,620135,458May 03 04:34 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthMay 01Option Exercise0.0020,0000153,201May 03 04:34 PM
Shaw ChristiSVP and Pres., Lilly Bio-MedsMay 01Option Exercise0.0013,750013,750May 03 04:29 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAMay 01Option Exercise0.0020,0000158,468May 03 04:26 PM
LILLY ENDOWMENT INC10% OwnerApr 25Sale80.85180,00014,553,614122,895,804Apr 26 12:38 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 16Sale80.0817,3791,391,71028,273Apr 17 03:29 PM
Mahony SusanSVP & Pres., Lilly OncologyApr 13Sale80.145,165413,92345,652Apr 17 03:29 PM
Smiley Joshua LSVP and CFOMar 16Sale79.203,000237,60020,029Mar 20 12:06 PM
Zakrowski Donald AChief Accounting OfficerMar 01Sale76.5086065,7901,637Mar 05 03:30 PM
Zakrowski Donald AChief Accounting OfficerFeb 21Sale77.5587667,9342,472Feb 23 05:42 PM
Norton JohnaSenior VP, Global QualityFeb 16Option Exercise0.0048048Feb 21 10:28 AM
Zakrowski Donald AChief Accounting OfficerFeb 05Sale81.0990072,9814,130Feb 05 06:39 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 05Sale81.129,625780,780133,201Feb 05 06:37 PM
O'Neill MylesSVP & Pres., Mfg. OperationsFeb 01Option Exercise0.009,596080,234Sep 24 04:45 PM
Simmons Jeffrey NSVP&Pres. Elanco Animal HealthFeb 01Option Exercise0.0021,3260152,120Feb 05 06:37 PM
Zulueta Alfonso GSVP & President, Lilly Int'lFeb 01Option Exercise0.0015,993065,357Feb 05 06:33 PM
Ricks David APresident & CEOFeb 01Option Exercise0.0021,3260140,809Feb 05 06:31 PM
Mahony SusanSVP & Pres., Lilly OncologyFeb 01Option Exercise0.0021,326060,350Feb 05 06:24 PM
Lundberg Jan MEVP,Science&Tech and Pres. LRLFeb 01Option Exercise0.0036,2520214,295Feb 05 06:21 PM
Harrington Michael JSenior VP and General CounselFeb 01Option Exercise0.0024,5240102,738Feb 05 06:19 PM
Fry Stephen FSVP, HR & DiversityFeb 01Option Exercise0.0017,0600107,820Feb 05 06:15 PM
Conterno Enrique ASVP&Pres, LillyDiab & LillyUSAFeb 01Option Exercise0.0021,3260147,980Feb 05 06:12 PM
Barnes Melissa SChief Eth/Cmpl Ofcr & SVP, ERMFeb 01Option Exercise0.006,398022,107Feb 05 06:09 PM